Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 848

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 848
---
 IF NO SPECIFICDIRECTION IS GIVEN AS TO THE PROPOSALS ON THE REVERSE SIDE, THIS PROXY WILL BEVOTED “FOR” EACH OF PROPOSAL NOS. 1, 2, 3, 4, 6 AND 7, AND FOR EACH OF THE PROPOSALSIN PROPOSAL 5, AND IN ACCORDANCE WITH THE JUDGMENT OF THE PROXY ON ANY OTHERMATTERS AS MAY PROPERLY COME BEFORE THE SPECIAL MEETING.PLEASE MARK, SIGN, DATE AND RETURN THE PROXY CARD PROMPTLY.(Continued and to be marked, dated and signed on the reverse side)

<div align='center'>K-1</div>

TABLE OF CONTENTS

2025(1) The Business Combination Proposal –To (a) adopt the Business CombinationAgreement, dated as of November 30, 2022,as amended, by and among Iris, Iris ParentHolding Corp., a Delaware corporation (“ParentCo”), LiminatusPharma, LLC, a Delaware limited liability company (“Liminatus”),Liminatus Pharma Merger Sub, Inc., a Delaware corporation andwholly-owned subsidiary of ParentCo (“Liminatus Merger Sub”), andSPAC Merger Sub, Inc., a Delaware corporation and wholly-ownedsubsidiary of ParentCo (“SPAC Merger Sub”), which provides, amongother things, that (i) Liminatus Merger Sub will merge with and intoLiminatus (the “Liminatus Merger”), with Liminatus surviving theLiminatus Merger as a direct wholly-owned subsidiary of ParentCo,and (ii) simultaneously with the Liminatus Merger, SPAC Merger Subwill merge with and into Iris (the “SPAC Merger” and, together withthe Liminatus Merger, the “Mergers”), with Iris surviving the SPACMerger (the “SPAC Surviving Subsidiary”) as a direct wholly- ownedsubsidiary of ParentCo (the transactions contemplated by theforegoing clauses (i) and (ii) the “Business Combination”), and (b)approve the Business Combination, as described in more detail inthe attached proxy statement/prospectus.(2) The Nasdaq Proposal – To approve, asrequired by the rules of the Nasdaq StockMarket LLC, the issuance of ParentCoCommon Stock in the Business Combination(including the PIPE Investor’s commitment to purchase 1,500,000shares of Parent